Clinical trial
A Pilot Study to Evaluate the Response and Tolerability of Verzenio (Abemaciclib) in Patients With Advanced Biliary Tract Carcinoma
NCT04003896 is registered in ClinicalTrials.gov with Milton S. Hershey Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study to Evaluate the Response and Tolerability of Verzenio (Abemaciclib) in Patients With Advanced Biliary Tract Carcinoma
- Lead sponsor
- Milton S. Hershey Medical Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 24, 2021
- Completion date
- August 15, 2023
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biliary tract carcinoma